Literature DB >> 1708538

Glutamate, nitric oxide and cell-cell signalling in the nervous system.

J Garthwaite1.   

Abstract

Nitric oxide (NO) is a recently discovered and highly unorthodox messenger molecule. Current evidence indicates that, in the CNS, NO is produced enzymatically in postsynaptic structures in response to activation of excitatory amino acid receptors. It then diffuses out to act on neighbouring cellular elements, probably presynaptic nerve endings and astrocyte processes. In several peripheral nerves, and quite possibly in parts of the CNS as well, NO might be formed presynaptically and thus act as a neurotransmitter. In both cases, a major action of NO is to activate soluble guanylate cyclase and so raise cGMP levels in target cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708538     DOI: 10.1016/0166-2236(91)90022-m

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  304 in total

Review 1.  Nitric oxide: discovery and impact on clinical medicine.

Authors:  S Moncada
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

2.  Ultrastructural localisation of NADPH-d/nNOS expression in the superior cervical ganglion of the hamster.

Authors:  C Y Tseng; J H Lue; H M Chang; C Y Wen; J Y Shieh
Journal:  J Anat       Date:  2000-10       Impact factor: 2.610

3.  Application of a novel technique for clinical evaluation of nitric oxide-induced free radical reactions in ICU patients.

Authors:  N Hayashi; A Utagawa; K Kinoshita; T Izumi
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

4.  The effects of nitrite on the excitability of brain neurons in the common snail.

Authors:  T L D'yakonova; V P Reutov
Journal:  Neurosci Behav Physiol       Date:  2000 Mar-Apr

5.  A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea-pig suprachiasmatic nucleus.

Authors:  S J Starkey; A L Grant; R M Hagan
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

6.  Mechanisms Involved in the Remyelinating Effect of Sildenafil.

Authors:  Daniela Díaz-Lucena; María Gutierrez-Mecinas; Beatriz Moreno; José Lupicinio Martínez-Sánchez; Paula Pifarré; Agustina García
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-03       Impact factor: 4.147

Review 7.  Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Thomas Louis
Journal:  Brain Res Rev       Date:  2007-06-12

8.  Lamotrigine differently modulates 7-nitroindazole and L-arginine influence on rat maximal dentate gyrus activation.

Authors:  P Sardo; S D'Agostino; F Carletti; V Rizzo; V La Grutta; G Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

Review 9.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

10.  Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia.

Authors:  I P Everall; J D Glass; J McArthur; E Spargo; P Lantos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.